Industry Symposium: Optimizing local therapy in early breast cancer: The role of genomic biomarkers DCISionRT and AidaBreast
Supported by PreludeDx
Saturday, October 10, 2026 | Hall C (Room M1)
07:30-08:00
Light refreshments will be served outside the hall from 07:00-07:30 for session participants only.
Admission to this symposium is included as part of the congress registration
| Chairperson: | Alastair Thompson, Indianapolis, IN, USA |
| 07:30-07:50 | AidaBreast®: Personalizing treatment decisions for early-stage invasive breast cancer Naamit Gerber, New York, NY, USA |
| 07:50-08:10 | Interim analysis of the PREDICT study: A 7-gene biosignature predicts radiation benefit in DCIS Yvonne Zissiadis, Perth, Australia |
| 08:10-08:30 | Discussion board: Clinical utility of biomarker tests for DCIS Bruce Mann, Melbourne, Australia Ben Green, Brisbane, Australia Naamit Gerber, New York, NY, USA Yvonne Zissiadis, Perth, Australia Alastair Thompson, Indianapolis, IN, USA |